Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pineal Res ; 47(3): 253-9, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19732300

RESUMO

Previous studies showed that melatonin or dehydroepiandrosterone (DHEA) enhances the immune response against parasitic pathogens. The present study investigated the in vitro activity of melatonin combined with DHEA in a period of 24 hr during the course of in vivo T. cruzi infection. The in vitro activity of melatonin or DHEA alone, as well as together, were tested for the trypomastigote forms (doses ranging from 0.5 to 128 microm). In vitro, neither melatonin nor DHEA alone had any activity against trypomastigote forms, although when the highest concentration of combined melatonin and DHEA was used, it was active against the trypomastigote forms of the parasite. However, for this concentration, a quite toxicity on peritoneal macrophages was observed. For in vivo evaluation, male Wistar rats were infected with the Y strain of T. cruzi. They were orally treated with 10 mg/kg body weight/day of melatonin and subcutaneously with 40 mg/kg body weight/day of DHEA. Treatment with melatonin, DHEA and the association showed a significant reduction in the number of blood trypomastigotes during the acute phase of infection as compared to untreated animals (P < 0.05). A significant increase in the number of macrophages and nitric oxide (NO) concentrations were observed during the peak of parasitaemia with melatonin alone or combined with DHEA. However, with DHEA alone the highest concentration of NO was observed (P < 0.05). Moreover, DHEA treatment increased TNF-alpha levels during the infection (P < 0.05). These results show that melatonin, DHEA or the combination of both reduces parasitemia during the acute phase of infection. The combined action of both molecules did not exert a synergic action on the host's ability to fight infection, and it seems that among all treatments DHEA induces a more efficient immune response.


Assuntos
Adjuvantes Imunológicos/uso terapêutico , Antioxidantes/uso terapêutico , Doença de Chagas/tratamento farmacológico , Desidroepiandrosterona/uso terapêutico , Melatonina/uso terapêutico , Trypanosoma cruzi/efeitos dos fármacos , Animais , Combinação de Medicamentos , Sinergismo Farmacológico , Macrófagos/efeitos dos fármacos , Macrófagos/metabolismo , Masculino , Parasitemia/tratamento farmacológico , Ratos , Ratos Wistar , Fator de Necrose Tumoral alfa/metabolismo
2.
J Pineal Res ; 47(3): 271-6, 2009 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-19709396

RESUMO

Gonadal steroids exert an important influence on the host immune response during infection. Changes resulting from the absence or replacement of gonadal hormones may represent a distinct evolution of a particular parasite. Taking into account the greater susceptibility of males to parasites, the magnitude of the immune response seems to depend on the interaction of many hormones that will act synergistically with other immune cells. The aims of this research were to evaluate the effects of the luck of male sex hormones due to orchiectomy, and the influence of oral administration of melatonin on the immune response of male Wistar rats infected with the Y strain of Trypanosoma cruzi. The percentage of CD3(+) CD4(+) and CD3(+) CD8(+) lymphocyte T cell subsets were evaluated using flow cytometry and the measurement of IL-2 and IL-12. For all parameters examined, a synergistic action of melatonin and orchiectomy on the host's immune response was observed, promoting an effective response against the parasite during the acute phase of infection. These results offer insight into other possibilities for possibly controlling T. cruzi proliferation through melatonin therapy and also the stimulatory effects on host's immune response triggered by the absence of male gonadal steroids during the acute phase of infection.


Assuntos
Doença de Chagas/tratamento farmacológico , Doença de Chagas/imunologia , Melatonina/farmacologia , Melatonina/uso terapêutico , Orquiectomia , Linfócitos T/efeitos dos fármacos , Animais , Complexo CD3/metabolismo , Linfócitos T CD4-Positivos/efeitos dos fármacos , Linfócitos T CD4-Positivos/imunologia , Depressores do Sistema Nervoso Central/farmacologia , Depressores do Sistema Nervoso Central/uso terapêutico , Citometria de Fluxo , Interleucina-12/metabolismo , Interleucina-2/metabolismo , Masculino , Ratos , Ratos Wistar , Linfócitos T/imunologia , Trypanosoma cruzi
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...